Lasa Supergenerics Ltd

Lasa Supergenerics Q1 FY26 Results: Revenue Drops, Net Loss Widens Amid Fire Incident 🔥📉

- Revenue from Operations for Q1 FY26: ₹2,001.18 lakhs (down from ₹3,083.55 lakhs in Q1 FY25)

- Total Income for Q1 FY26: ₹2,014.60 lakhs (vs ₹3,084.02 lakhs in Q1 FY25)

- Net Loss after tax for Q1 FY26: ₹2,111.92 lakhs (vs loss of ₹273.10 lakhs in Q1 FY25)

- Fire incident on May 15, 2025, caused significant damage to inventories (₹1,200.02 lakhs), property, plant & equipment (provisional), and other expenses (₹83.85 lakhs). Assets were uninsured.

- Operations at all units ceased as Mother Unit was central to production.

- Management exploring options like contract manufacturing or leasing the facility, pending approvals.

- Bank balance confirmations for dormant accounts (₹7.99 lakhs) and fixed deposits (₹31.46 lakhs) could not be obtained.

- Company operates in a single business segment: Active Pharmaceutical Ingredients (API).

- Auditor's limited review report highlighted fire incident and operational challenges but found no other material misstatements.